OXFORD LABORATORIES LIMITED

Company Registration Number:
03481181 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2022

Period of accounts

Start date: 1 January 2022

End date: 31 December 2022

OXFORD LABORATORIES LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2022

Balance sheet
Additional notes
Balance sheet notes

OXFORD LABORATORIES LIMITED

Balance sheet

As at 31 December 2022

Notes 2022 2021


£

£
Fixed assets
Investments: 3 100,992 100,992
Total fixed assets: 100,992 100,992
Current assets
Debtors: 4 344,574 307,808
Cash at bank and in hand: 14,318 21,820
Total current assets: 358,892 329,628
Creditors: amounts falling due within one year: 5 ( 455,932 ) ( 456,594 )
Net current assets (liabilities): (97,040) (126,966)
Total assets less current liabilities: 3,952 ( 25,974)
Total net assets (liabilities): 3,952 (25,974)
Capital and reserves
Called up share capital: 10,000 10,000
Profit and loss account: (6,048 ) (35,974 )
Total Shareholders' funds: 3,952 (25,974)

The notes form part of these financial statements

OXFORD LABORATORIES LIMITED

Balance sheet statements

For the year ending 31 December 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 31 October 2023
and signed on behalf of the board by:

Name: Mr A Medounitsyn
Status: Director

The notes form part of these financial statements

OXFORD LABORATORIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Other accounting policies

    These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

OXFORD LABORATORIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

  • 2. Employees

    2022 2021
    Average number of employees during the period 2 2

OXFORD LABORATORIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

3. Fixed assets investments note

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value being recognised in profit or loss.

OXFORD LABORATORIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

4. Debtors

2022 2021
£ £
Trade debtors 344,574 307,808
Total 344,574 307,808

OXFORD LABORATORIES LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2022

5. Creditors: amounts falling due within one year note

2022 2021
£ £
Trade creditors 368,069 378,510
Other creditors 87,863 78,084
Total 455,932 456,594